| 注册
首页|期刊导航|中成药|基于HPLC指纹图谱及含量测定完善复方鱼腥草片质量

基于HPLC指纹图谱及含量测定完善复方鱼腥草片质量

艾光丽 王欣 李及 李婷婷 罗霄 马双成

中成药2025,Vol.47Issue(11):3548-3554,7.
中成药2025,Vol.47Issue(11):3548-3554,7.DOI:10.3969/j.issn.1001-1528.2025.11.003

基于HPLC指纹图谱及含量测定完善复方鱼腥草片质量

Quality improvement of Compound Yuxingcao Tablets based on HPLC fingerprints and content determination

艾光丽 1王欣 1李及 1李婷婷 1罗霄 1马双成2

作者信息

  • 1. 成都市药品检验研究院,四川成都 610045||国家药品监督管理局中药材质量监测评价重点实验室,四川成都 610045
  • 2. 国家药典委员会,北京 100061||药品监管科学全国重点实验室,北京 100061
  • 折叠

摘要

Abstract

AIM To improve the quality of Compound Yuxingcao Tablets.METHODS The HPLC fingerprints were established,after which the contents of neochlorogenic acid,chlorogenic acid,cryptochlorogenic acid,forsythoside I,forsythoside A,quercitrin,3,5-O-dicaffeoylquinic acid,4,5-O-dicaffeoylquinic acid,baicalin,oroxyloside,wogonin and baicalein were determined.The analysis was performed on a 30 ℃ thermostatic Waters XBridge C18 column(250 mm×4.6 mm,5 μm),with the mobile phase comprising of acetonitrile-0.1%phosphoric acid flowing at 1.0 mL/min in a gradient elution manner,and the detection wavelength was set at 327 nm.Subsequently,principal component analysis and orthogonal partial least squares discriminant analysis were adopted.RESULTS There were 21 common peaks in the fingerprints for 22 batches of samples with the similarities of more than 0.85.Twelve constituents showed good linear relationships within their own ranges(R20.999 8),whose average recoveries were 93.68%-101.16%with the RSDs of 0.95%-2.35%.Baicalin,wogonin and forsythoside A were taken as quality differential components.CONCLUSION This simple and accurate method can be used for the quality control of Compound Yuxingcao Tablets.

关键词

复方鱼腥草片/质量完善/HPLC指纹图谱/含量测定/主成分分析/正交偏最小二乘法判别分析

Key words

Compound Yuxingcao Tablets/quality improvement/HPLC fingerprints/content determination/principal component analysis/orthogonal partial least squares discriminant analysis

分类

医药卫生

引用本文复制引用

艾光丽,王欣,李及,李婷婷,罗霄,马双成..基于HPLC指纹图谱及含量测定完善复方鱼腥草片质量[J].中成药,2025,47(11):3548-3554,7.

基金项目

国家重点研发计划-中医药现代化专项(2023YFC3504100) (2023YFC3504100)

中成药

OA北大核心

1001-1528

访问量0
|
下载量0
段落导航相关论文